Alcon Research, Ltd. recalls 23G and 25G Constellation Totalplus Paks provides access into the posterior segment of the eye for surgical instruments…
- Recall date
- August 11, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1693-2016
- FDA classification
- Class II
- Brand / firm
- Alcon Research, Ltd.
- Sold / distributed
- United States, Argentina, Armenia, Australia, Azerbaijan, Bangladesh, Brbados, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Curacao, Cypress, Denmark, Ecuador, Finland, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Lsreal, Italy, Japan, Korea, Lithuania, Malta, Mexico,…
Why it was recalled
The product has potential to leak beyond their design specification.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
23G and 25G Constellation Totalplus Paks provides access into the posterior segment of the eye for surgical instruments within the frame of 23G and 25G Pars-Plana-Vitrectomy (PPV) surgeries.
Get recall alerts
Free email alert whenever Alcon Research, Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alcon Research, Ltd.